Author Affiliations: Departments of Medicine (Dr Golomb and Ms Koperski) and Family and Preventive Medicine (Dr Golomb), University of California, San Diego, La Jolla.
We concur with Tarapués and colleagues. An analysis we conducted of patient reports of muscle problems (including fatigue)1 is in agreement with their Spanish data, extending fatigue adverse effects (AEs) to all statins. These data suggest that risk approximately parallels statin potency, as does our recent analysis of the US Food and Drug Administration AE reports focused on muscle-related AEs,2 although this latter analysis did not expressly address fatigue.
Golomb BA, Koperski S. New Statins Also Produce Fatigue: Spontaneous Reporting as a Complementary System to Increase Safety Knowledge—Reply. JAMA Intern Med. 2013;173(3):247-248. doi:10.1001/jamainternmed.2013.2113